Douglas C. Lane & Associates’s Sanofi SNY Stock Holding History

Douglas C. Lane & Associates’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$14.8M	Sell	347,699 -39,835	-10%	-$1.83M	0.4%	86
2015 Q3	$18.4M	Sell	387,534 -16,559	-4%	-$843K	0.52%	72
2015 Q2	$20M	Sell	404,093 -23,337	-5%	-$1.18M	0.54%	69
2015 Q1	$21.1M	Buy	427,430 +12,317	+3%	+$589K	0.56%	69
2014 Q4	$18.9M	Buy	415,113 +4,495	+1%	+$218K	0.51%	77
2014 Q3	$23.2M	Buy	410,618 +12,725	+3%	+$683K	0.69%	60
2014 Q2	$21.2M	Buy	397,893 +5,755	+1%	+$305K	0.64%	66
2014 Q1	$20.5M	Buy	392,138 +55,609	+17%	+$2.81M	0.66%	63
2013 Q4	$18M	Buy	336,529 +14,176	+4%	+$731K	0.6%	73
2013 Q3	$16.3M	Buy	322,353 +43,467	+16%	+$2.21M	0.6%	71
2013 Q2	$14.4M	Buy	+278,886	New	+$14.9M	0.56%	77

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Douglas C. Lane & Associates's SNY Position: Q4 2015 in Review

Douglas C. Lane & Associates reduced its Sanofi (SNY) stake by 10% in Q4 2015, selling an estimated $1.83M and leaving 347,699 shares worth $14.8M. The position accounts for 0.4% of the portfolio, ranked #86.

Douglas C. Lane & Associates first reported a position in SNY in Q2 2013 and has held it in 11 quarters since. The position peaked at $23.2M in Q3 2014. 477 funds tracked by Wall St. Rank hold SNY as of Q4 2015.

Douglas C. Lane & Associates held 347,699 shares of Sanofi worth $14.8M as of Q4 2015.
Douglas C. Lane & Associates sold 39,835 Sanofi shares in Q4 2015, an estimated $1.83M.
Sanofi made up 0.4% of Douglas C. Lane & Associates's portfolio in Q4 2015, its #86 holding.
Douglas C. Lane & Associates first reported a position in Sanofi in Q2 2013 and has held it in 11 quarters since.
Douglas C. Lane & Associates's Sanofi position peaked at $23.2M in Q3 2014.
477 funds tracked by Wall St. Rank held Sanofi as of Q4 2015.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2015, filed 25 Jan 2016.